Description

Topiramate Tablets

Healthy Inc is a specialized global supplier and exporter of advanced neurological, psychiatric, and chronic pain management therapeutics. We provide ultra-high-purity, kinetically precise Topiramate Tablets (25 mg / 50 mg / 100 mg / 200 mg), manufactured in WHO–GMP certified, high-capacity oral solid dosage facilities. This “Multi-Mechanism Neuromodulator” is a massive-volume, essential export to neurology centers, headache/migraine clinics, psychiatric networks, and government health ministries in LATAM, the Middle East, Africa, and Southeast Asia, serving as the globally trusted intervention for epilepsy management and the definitive first-line prophylaxis for chronic migraines.

Product Overview

This formulation contains Topiramate, a structurally unique sulfamate-substituted monosaccharide that acts as a profound, broad-spectrum central nervous system depressant by targeting multiple distinct neurological pathways simultaneously.

The “Multi-Target Seizure & Migraine” Specialist:

• Mechanism (The Triple-Action Blockade): Unlike older drugs that target a single receptor, Topiramate forcefully quiets an overactive brain through three distinct mechanisms: 1) It blocks voltage-dependent sodium channels, preventing neurons from firing rapidly. 2) It heavily augments the activity of the brain’s primary inhibitory neurotransmitter, GABA. 3) It physically blocks the AMPA/kainate receptors, neutralizing the brain’s primary excitatory neurotransmitter, glutamate. Additionally, it acts as a weak carbonic anhydrase inhibitor.
• The Migraine Prophylaxis Gold Standard: While painkillers treat a migraine after it starts, Topiramate is the globally mandated preventative therapy. By permanently raising the neurological “threshold” required to trigger a cortical spreading depression, it drastically reduces the frequency, severity, and duration of debilitating chronic migraines.
• Broad-Spectrum Epilepsy Control: Because it attacks seizures from multiple biochemical angles, Topiramate is highly effective as both monotherapy and adjunctive therapy for partial-onset seizures, primary generalized tonic-clonic seizures, and the notoriously difficult-to-treat Lennox-Gastaut syndrome.

Product Composition & Strength

We supply this product as a Precision-Blended Film-Coated Tablet, packed in highly secure, moisture-resistant Alu-Alu blister strips to guarantee absolute stability of the active pharmaceutical ingredient across diverse climate zones.

*Pack Sizes: 10×10 or 10×14 Alu-Alu Blisters (Optimized for strict, multi-week dose titration and chronic dispensing regimens).

Technical & Logistics Specifications

Critical data for Pharmaceutical Importers, Neurology Distributors, and Chronic Pain Clinics.

Manufacturing Authority

Marketed and Distributed by Healthy Inc from WHO-GMP & ISO 9001:2015 certified units.

• Titration-Dose Geometric Blending: Because Topiramate therapy *must* be initiated at very low doses (25mg) to prevent severe cognitive impairment, our manufacturing utilizes advanced high-shear homogenizers and rigorous geometric dilution protocols. This ensures absolute, flawless dose uniformity in the low-strength tablets, preventing toxic “hot spots” that would cause a patient to abandon therapy.
• Broad Dose-Range Output: From the 25mg migraine dose to the massive 200mg epilepsy dose, our automated compression lines ensure consistent kinetic release profiles across the entire spectrum, providing reliable steady-state blood levels for complex neurological management.

Therapeutic Indications (Human Use)

Indicated for the comprehensive management of severe neurological hyperactivity:

• Migraine Prophylaxis: Indicated for the preventive treatment of migraine in patients 12 years of age and older. (Note: It is not indicated for the acute treatment of migraine attacks).
• Epilepsy (Monotherapy & Adjunctive): Initial monotherapy in patients 2 years of age and older with partial-onset or primary generalized tonic-clonic seizures. Adjunctive therapy for adults and pediatric patients with seizures associated with Lennox-Gastaut syndrome.

Dosage & Administration

Recommended Dosage (Strictly as per Neurologist Guidelines):

• The “Start Low, Go Slow” Protocol: Topiramate is globally notorious for causing cognitive side effects if the dose is escalated too quickly. Therapy usually begins at 25 mg taken at night for the first week, increasing by 25 mg per week until the target maintenance dose is achieved (usually 50-100 mg/day for migraines, up to 400 mg/day for epilepsy).
• Administration (HYDRATION IS CRITICAL): Because of its weak carbonic anhydrase inhibition, it can cause kidney stones. Patients MUST drink copious amounts of water throughout the day to prevent stone formation.
• Discontinuation: Like all anticonvulsants, Topiramate must be tapered off slowly to prevent the triggering of rebound seizures or status epilepticus.

Safety Warnings (CRITICAL Regulatory & Clinical Data):

• Cognitive Dulling (“Dopamax” Effect): Topiramate frequently causes psychomotor slowing, difficulty with concentration/attention, and severe word-finding difficulties (expressive aphasia). Patients must be warned about this, as it can significantly impact their ability to work or drive, especially during the initial dose titration.
• Acute Myopia and Secondary Angle Closure Glaucoma: A rare but severe syndrome characterized by sudden decreases in visual acuity and extreme eye pain. It typically occurs within 1 month of initiating therapy. If suspected, the drug must be discontinued immediately to prevent permanent vision loss.
• Metabolic Acidosis & Oligohidrosis: Can cause hyperchloremic, non-anion gap metabolic acidosis. Additionally, it decreases sweating (oligohidrosis) and elevates body temperature, particularly in pediatric patients exposed to hot weather.
• Teratogenicity: Can cause fetal harm, specifically a significantly increased risk of cleft lip and cleft palate if used during the first trimester of pregnancy.

Global Export & Contract Manufacturing Services

Healthy Inc stands as a premier Pharmaceutical Exporter in India, dedicated to serving the needs of international Pharma Traders, Wholesalers, and Retail Pharmacy Networks. As a verified Medicine Supplier in Mumbai, we offer flexible Third Party Manufacturing (Contract Manufacturing) services for Advanced Neurological Formulations, allowing brands to launch high-quality generic medicines under their own label. Whether you are looking for a reliable Hospital Tender Supplier for national epilepsy programs in Africa or a B2B Pharma Marketplace partner for Latin America, our logistics network ensures timely delivery. We actively support Pharmaceutical Drop Shipping models and bulk indenting, ensuring that every Generic Medicine Wholesaler receives WHO-GMP certified products at competitive rates.